Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05231 (
interleukin-6
)
23,907
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Plasma values of immunoreactive
interleukin-6
,
C-reactive protein
and phospholipase A have been determined in serial samples from 24 patients with acute pancreatitis ('mild' pancreatitis nine, 'severe' pancreatitis 15). Median plasma concentrations of
interleukin-6
,
C-reactive protein
, and phospholipase A activity were significantly higher in patients with 'severe' illness (p < 0.001) than those with 'mild' illness. A particularly marked increase in
interleukin-6
was found in two patients with necrotising pancreatitis and fatal outcome. Significant correlations between plasma concentrations of
interleukin-6
and phospholipase A (p = 0.0218) and
C-reactive protein
and phospholipase A activity (p < 0.0001) were found in patients with 'severe' disease. These findings in a limited number of patients with acute pancreatitis are promising in that raised
interleukin-6
correlated with clinical severity and with two other established markers,
C-reactive protein
, and phospholipase A activity.
...
PMID:Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. 142 82
Cytosolic aminopeptidase P was obtained in highly purified form from human leukocytes by a four-step procedure. Buffy coats were the starting material. A M(r) of 140,000 was obtained by size-exclusion HPLC for the native enzyme. As shown by SDS/PAGE under reducing and denaturing conditions, the enzyme consisted of likely identical subunits with M(r) of 71,000. Purified aminopeptidase P cleaved off, specifically and efficiently, the N-terminal residues from peptides with N-terminal Xaa-Pro sequences. The penultimate proline was not replaceable by hydroxyproline, alanine and glycine in di-, tri- and tetrapeptides. Polyproline was not hydrolyzed. Dipeptides were cleaved (Arg-Pro, Phe-Pro > Trp-Pro > Pro-Pro) although slower than longer peptides. Cleavage was observed of several biologically active peptides; C-terminal fragment (residues 201-206) of
C-reactive protein
, oxytocin fragment Tyr-Pro-Leu-Gly, morphiceptin, peptide Gly-Pro-Arg-Pro (inhibitor of fibrin polymerization) and kentsin. In addition, cleavage of a protein,
interleukin-6
, was also demonstrated. Aminopeptidase P was maximally activated by Mn2+, and to a lesser extent by Co2+. The activity was optimal at pH 8. Ni2+, Zn2+ and especially Cd2+ caused marked inhibition. EDTA, 1,10-phenantroline and dithiothreitol were also inhibitory. Carbobenzoxy-phenylalanine, as well as several N-carbobenzoxy-proline-containing peptides, caused partial inhibition. The observed resistance of Gly-Pro, Pro-Gly, Pro-Phe and Pro-Ile to hydrolysis by the purified enzyme strongly indicates absence of known proline-specific dipeptidases in the aminopeptidase-P preparation.
...
PMID:Aminopeptidase P from human leukocytes. 144 89
Due to the stress imposed by the process of bone marrow transplantation (BMT), we hypothesized that individuals receiving such a transplant underwent an acute phase response (APR). Circulating levels of
C-reactive protein
(
CRP
), haptoglobin (HAP), alpha-1 acid glycoprotein (AAG), ceruloplasmin (CER), zinc (Zn), copper (Cu),
interleukin-6
(
IL-6
), albumin (ALB), and thyroxine-binding prealbumin (TBPA), were measured at baseline (Day -7), Day -4, Day 0 (Transplant Day), Day +2, +7, and weekly until day 28 in 14 adults receiving an autologous bone marrow transplant as Phase 1 treatment for various hematologic or solid tumor malignancies. Ten of 14 recipients survived, 9 of which had a significant increase in
CRP
(p = 0.012), HAP (p = 0.011), AAG (p = 0.002), and decrease in ALB (p = 0.002) and TBPA (p = 0.004) on Day +7, but not Day 0, after bone marrow reinfusion. These findings document the presence of an APR and suggest that the bone marrow transplant process (post reinfusion) initiates a stress response in the recipient.
...
PMID:The acute phase response in autologous bone marrow transplantation. 147 99
Plasma
Interleukin-6
(
IL-6
) level was measured in 60 patients with disseminated intravascular coagulation (DIC). Plasma
IL-6
level was high in patients with DIC, and was particularly high in patients with multiple organ failure (MOF) or poor prognosis. Plasma
IL-6
level correlated positively with
C-reactive protein
in patients without DIC, but not in those with DIC. The increased plasma
IL-6
level observed in DIC patients suggests that activation of the immune system is involved in the progression of DIC and in the pathology of organ failure.
...
PMID:[Plasma interleukin-6 in patients with disseminated intravascular coagulation]. 147 90
Inhalation of 20 micrograms endotoxins (from the membrane of Gram-negative bacteria) has been reported to induce a bronchial obstructive response in asthmatic subjects. The aim of the present study was to evaluate in asthmatic patients the possibility of an inflammatory response to inhaled endotoxins. Eight patients with mild asthma were submitted to bronchial challenge tests, in a single-blind trial, on Day 1 with control solution and on Day 7 with 20 micrograms endotoxin of Escherichia coli (026:B6). Local inflammatory response was indirectly evaluated by the degree of bronchial hyperresponsiveness (BHR) expressed as PD20 FEV1 histamine (the dose of histamine inducing a 20% decrease in FEV1) at 0, 6, 24, and 48 h and 7 days. Systemic inflammation was investigated by sequential blood determinations of total (and differential) white cells, complement anaphylatoxin C5a,
interleukin-6
(
IL-6
), tumor necrosis factor alpha (TNF-alpha), and
C-reactive protein
(
CRP
). A significant (p < 0.01) bronchial obstructive response was demonstrable 45 min after lipopolysaccharide (LPS) inhalation, lasting 5 h. Comparing the level of BHR after control inhalation, a significant (p < 0.05) increase in BHR was shown 6 h after LPS, partially normalized at 24 and 48 h. A short peak in TNF-alpha at 60 min (p < 0.05) and an increase in total white blood cells (p < 0.01) and neutrophil polymorphonuclear neutrophils at 360 min (p < 0.05) and of
CRP
at 24 and 48 h (p < 0.05 and p < 0.01) were significant. The other blood parameters did not change significantly.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Inflammatory response to acute inhalation of endotoxin in asthmatic patients. 148 24
The mucosal and systemic
interleukin-6
(
IL-6
) response to urinary tract infection was analyzed in women with acute pyelonephritis or asymptomatic bacteriuria. Urine and serum samples were obtained at diagnosis and after treatment.
IL-6
activity was elevated in urine samples from most bacteriuric women, regardless of the severity of infection. Urinary levels greater than 20 units/mL occurred in 25 of 29 women with acute pyelonephritis and in 36 of 42 women with asymptomatic bacteriuria. Elevated serum
IL-6
levels were found mainly in patients with acute pyelonephritis: Levels greater than 20 units/mL occurred in 14 of 28 women with acute pyelonephritis compared with 0 of 28 women with asymptomatic bacteriuria. These results suggest that bacteriuria is accompanied by elevated urinary
IL-6
levels and that this
IL-6
is locally produced. The spread of
IL-6
to the circulation in patients with acute pyelonephritis may contribute to the elevation of fever and
C-reactive protein
characteristic of the disease.
...
PMID:Comparison of urine and serum concentrations of interleukin-6 in women with acute pyelonephritis or asymptomatic bacteriuria. 150 Jul 53
A sensitive enzyme-linked immunosorbent assay of human
interleukin-6
(
IL-6
) was developed to measure the serum
IL-6
by Fujirebio INC. Its sensitivity was 3 pg/ml and its analytical range was from 3 to 200 pg/ml. Its precision, reproducibility, and sensitivity were quite satisfactory. The serum
IL-6
levels in 200 normal individuals were less than 3 pg/ml. Serum
IL-6
concentration in patients with malignant and benign monoclonal gammopathy (BMG) was determined by an ELISA. Serum
IL-6
concentration in patients with Bence Jones protein (BJP) type multiple myeloma (MM) (n = 12) was 12.3 +/- 12.7 (mean +/- SD) pg/ml, BJP and IgG type MM (n = 4) 11.5 +/- 5.8 pg/ml, IgM type MM (n = 11) 11.1 +/- 17.5 pg/ml and IgA type MM (n = 4) 4.0 +/- 1.4 pg/ml. They were significantly higher in BJP, BJP and IgG, and IgM types than in normal individuals. The cases with the serum
IL-6
of more than 10 pg/ml were move frequent in MM (32.8%) than in BMG (16.3%). The correlation between the serum
IL-6
and
C-reactive protein
(
CRP
) was r = 0.563 in patients with MM (n = 61) and r = 0.498 in BMG (n = 43). Besides, during the clinical course of a patient with IgG-lambda and BJP-lambda type MM, serum
IL-6
concentration responded more sharply than
CRP
and WBC on candida infection. The measurement of serum
IL-6
therefore, seemed not useful for differential diagnosis of monoclonal gammopathies, but it seemed useful as an acute phase protein as well as
CRP
.
...
PMID:[Determination of serum interleukin-6 concentration by an enzyme-linked immunosorbent assay in patients with paraproteinemia]. 151 81
The biochemical nature of endogenous
interleukin-6
(
IL-6
) as it exists in human serum or plasma was investigated. Serum from a patient following bone marrow (BM) transplantation and fresh plasma samples from patients with epidermolysis bullosa or psoriasis, as well as from normal volunteers, were fractionated through G-200 columns and each of the eluted fractions assayed for IL (interleukin)-6 content using enzyme-linked immunosorbent assays (ELISAs) based on the monoclonal antibody (mAb) pairs IG61/5IL6 or 4IL6/5IL6 and in the B9
hybridoma growth factor
bioassay. The IG61/5IL6 ELISA and the B9 assay detected
IL-6
in BM serum almost exclusively of molecular mass approximately 20 kDa. In contrast, the 4IL6/5IL6 ELISA detected strong
IL-6
immunoreactivity in complexes of size 100-150 and 400-500 kDa.
IL-6
present in the 100-150- and 400-500-kDa complexes was purified by immunoaffinity chromatography through a 5IL6 mAb column. The 5IL6 mAb immunoaffinity column eluate of the respective pools from BM serum contained
IL-6
at concentrations approaching 1 microgram/ml as characterized by Western blotting. Sufficient
IL-6
and associated proteins were purified by 5IL6 mAb immunoaffinity column chromatography of the 100-150-kDa complex from 0.8 ml of BM serum to allow (i) verification of three of the polypeptides as
IL-6
by amino-terminal sequencing (estimate of
IL-6
in original serum sample: 5-10 micrograms/ml), (ii) identification by amino acid sequencing of the "associated" proteins as complement factor C3b (carboxyl-terminal of the alpha-chain), complement factor C4b (gamma-chain),
C-reactive protein
, and albumin, and (iii) detection of an "associated" polypeptide consistent with the soluble
IL-6
receptor. Taken together, these data establish that
IL-6
is present at unexpectedly high concentrations in human blood in novel biochemical complexes that include other plasma proteins, which in turn, can camouflage
IL-6
immunoreactivity and bioactivity as measured in conventional assays.
...
PMID:High levels of "complexed" interleukin-6 in human blood. 152 89
This study investigated the effect of prolonged rupture of the amniotic membranes (PROM) and probable maternal or fetal sepsis without PROM on the newborn preterm airway. Bronchoalveolar lavage fluid (BALF) was obtained from 38 infants in the first day of life and analyzed for number of white cells and concentration of
interleukin-6
(
IL-6
). The volume of lung epithelial lining fluid (ELF) was estimated using the urea dilution technique. Infants with PROM (n = 13) and those with sepsis (n = 8) had higher total numbers of white cells in BALF compared with infants without PROM or sepsis (n = 17) (55 and 44 versus 7 x 10(4) white cells, p less than 0.01). Uncorrected and urea-corrected
IL-6
concentrations were also higher in the two groups (18.5 and 30.8 versus 5.0 fmol/ml BALF, p less than 0.01; 157.7 and 444 versus 88.5 fmol/ml ELF, p less than 0.05). There was a significant correlation between BALF white cells and uncorrected
IL-6
concentrations (rs = 0.78, p less than 0.0001). Detectable serum
C-reactive protein
in newborn infants was associated with increased levels of
IL-6
in BALF (42.2 versus 11.8 fmol/ml BALF, p less than 0.05). We conclude that PROM is associated with airway inflammation and raised levels of
IL-6
in neonatal lung fluid within the first 24 h of life and that this may initiate a systemic stress response.
...
PMID:Increased levels of bronchoalveolar lavage fluid interleukin-6 in preterm ventilated infants after prolonged rupture of membranes. 155 2
The assessment of febrile neutropenia is problematic.
C-reactive protein
(
CRP
) values alone do not differentiate those patients with microbiologically documented infections from those with unexplained fevers. Plasma
interleukin-6
(
IL-6
), measured by ELISA, was correlated with different diagnostic groups in 47 episodes of febrile neutropenia in children. Samples were collected daily from admission until resolution of fever. On admission, the median
IL-6
value for gram-negative infections was 1610 pg/ml (range, 896-40,000), for gram-positive infections it was 138 pg/ml (range, 66-1045), and for unexplained fevers it was 50 pg/ml (range, 24-135, with a single high value of 665 pg/ml). These medians were significantly different (P less than .005). There was no significant difference in median
CRP
values.
IL-6
values peaked 24-48 h before
CRP
values. There was a positive correlation of
IL-6
with the presence of fever. Plasma
IL-6
may be a more sensitive marker than
CRP
of acute infection and should prove useful in the assessment of fevers in these patients.
...
PMID:Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. 156 38
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>